New Directions in Leukaemia Research (NDLR)

Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

Description

Eadie LN, Schutz CE, Page EC, Conlin TS, Heatley SL, Lagonik E, Rehn, JA, Yeung DT, Hughes TP, White DL
Asciminib is effective against ABL1 gene fusions in Acute Lymphoblastic Leukemia but only when the ABL1 SH3 domain is present
Adelaide, Australia
Rapid-fire Oral Presentation
Period4 Mar 2024 → 6 Mar 2024
Event titleNew Directions in Leukaemia Research (NDLR)
Event typeConference
LocationAdelaide, Australia, South AustraliaShow on map
Degree of RecognitionNational